Oncology News

The use of gadoxetic acid as a contrast agent for magnetic resonance can improve the sensitivity of hepatocellular carcinoma diagnosis in patients with cirrhosis, according to recent results.

The incidence of hepatocellular carcinoma has increased among patients coinfected with HIV and hepatitis, according to researchers in Spain.

Hepatocellular carcinoma ultrasonography surveillance conducted at 4-month intervals resulted in greater detection of smaller tumors among viral hepatitis patients than examination performed at 12-month intervals, according to study data.

Patients with hepatitis B genotype C are more likely to develop hepatocellular carcinoma than patients with other HBV genotypes, according to recent results.

Patients with low levels of prediagnostic adiponectin were approximately 40% more likely to develop pancreatic cancer than those with higher adiponectin levels, according to results of a nested case-control study.

A hepatocellular carcinoma surveillance program is not cost-effective for patients aged younger than 55 years who had high platelet counts, according to recent results.

Patients with hepatocellular carcinoma who undergo liver transplantation may be at reduced risk for disease recurrence and death when treated with sirolimus, according to recent results.

Cirrhotic patients infected with hepatitis B virus who consumed large quantities of alcohol were at increased risk for hepatocellular carcinoma compared with patients with either hepatitis B virus or alcoholism in a recent study.

Patients with diabetes who received metformin were at reduced risk for intrahepatic cholangiocarcinoma, while biliary tract disease, cirrhosis, diabetes and smoking increased that risk in a recent study.

BOSTON — Patients taking metformin may be at reduced risk for hepatocellular carcinoma, according to data presented at The Liver Meeting.